Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders

被引:147
作者
Agarwal, Swati [1 ,2 ]
Yadav, Anuradha [1 ,2 ]
Chaturvedi, Rajnish Kumar [1 ,2 ]
机构
[1] CSIR, IITR, Syst Toxicol & Hlth Risk Assessment Grp, Dev Toxicol Lab, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, CSIR IITR Lucknow Campus, Lucknow, Uttar Pradesh, India
关键词
Mitochondrial dysfunction; Neurodegenerative disorder; Mitochondrial dynamics; PGC-1; alpha; Mitochondrial biogenesis; Pioglitazone; Rosiglitazone; TRANSGENIC MOUSE MODEL; NF-KAPPA-B; NEUROBLASTOMA SH-SY5Y CELLS; GAMMA AGONIST PIOGLITAZONE; FATTY-ACID OXIDATION; RETINOID-X-RECEPTOR; P38 MAP KINASE; PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS;
D O I
10.1016/j.bbrc.2016.08.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors and they serve to be a promising therapeutic target for several neurodegenerative disorders, which includes Parkinson disease, Alzheimer's disease, Huntington disease and Amyotrophic Lateral Sclerosis. PPARs play an important role in the downregulation of mitochondrial dysfunction, proteasomal dysfunction, oxidative stress, and neuroinflammation, which are the major causes of the pathogenesis of neurodegenerative disorders. In this review, we discuss about the role of PPARs as therapeutic targets in neurodegenerative disorders. Several experimental approaches suggest potential application of PPAR agonist as well as antagonist in the treatment of neurodegenerative disorders. Several epidemiological studies found that the regular usage of PPAR activating non-steroidal anti-inflammatory drugs is effective in decreasing the progression of neurodegenerative diseases including PD and AD. We also reviewed the neuroprotective effects of PPAR agonists and associated mechanism of action in several neurodegenerative disorders both in vitro as well as in vivo animal models. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1166 / 1177
页数:12
相关论文
共 240 条
[1]
Antiobesity Effects of yerba mate Extract (Ilex paraguariensis) in High-fat Diet-induced Obese Mice [J].
Arcari, Demetrius P. ;
Bartchewsky, Waldemar ;
dos Santos, Tanila W. ;
Oliveira, Karim A. ;
Funck, Alexandre ;
Pedrazzoli, Jose ;
de Souza, Marina F. F. ;
Saad, Mario J. ;
Bastos, Deborah H. M. ;
Gambero, Alessandra ;
Carvalho, Patricia de O. ;
Ribeiro, Marcelo L. .
OBESITY, 2009, 17 (12) :2127-2133
[2]
Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases [J].
Archer, Stephen L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) :2236-2251
[3]
Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein [J].
Autiero, Ida ;
Costantini, Susan ;
Colonna, Giovanni .
PLOS ONE, 2009, 4 (10)
[4]
The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease [J].
Bae, Nayoung ;
Ahn, Taekwon ;
Chung, Sungkwon ;
Oh, Myung Sook ;
Ko, Hyeonseok ;
Oh, Hyungun ;
Park, Gunhyuk ;
Yang, Hyun Ok .
JOURNAL OF ETHNOPHARMACOLOGY, 2011, 134 (02) :313-322
[5]
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis [J].
Banerjee, Rebecca ;
Starkov, Anatoly A. ;
Beal, M. Flint ;
Thomas, Bobby .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07) :651-663
[6]
Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine [J].
Barbiero, Janaina K. ;
Santiago, Ronise M. ;
Persike, Daniele Suzete ;
da Silva Fernandes, Maria Jose ;
Tonin, Fernanda S. ;
da Cunha, Claudio ;
Boschen, Suelen Lucio ;
Lima, Marcelo M. S. ;
Vital, Maria A. B. F. .
BEHAVIOURAL BRAIN RESEARCH, 2014, 274 :390-399
[7]
PPAR-α. agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease [J].
Barbiero, Janaina K. ;
Santiago, Ronise ;
Tonin, Fernanda S. ;
Boschen, Suelen ;
da Silva, Luisa Mota ;
de Paula Werner, Maria Fernanda ;
da Cunha, Claudio ;
Lima, Marcelo M. S. ;
Vital, Maria A. B. F. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 53 :35-44
[8]
PPAR-γ agonist protects against intestinal injury during necrotizing enterocolitis [J].
Baregamian, Naira ;
Mourot, Joshua M. ;
Ballard, Amie R. ;
Evers, B. Mark ;
Chung, Dai H. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (02) :423-427
[9]
A single nucleotide in an estrogen-related receptor α site can dictate mode of binding and peroxisome proliferator-activated receptor γ coactivator 1α activation of target promoters [J].
Barry, JB ;
Laganière, J ;
Giguère, V .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (02) :302-310
[10]
Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease [J].
Bassaganya-Riera, J ;
Reynolds, K ;
Martino-Catt, S ;
Cui, YZ ;
Hennighausen, L ;
Gonzalez, F ;
Rohrer, J ;
Benninghoff, AU ;
Hontecillas, R .
GASTROENTEROLOGY, 2004, 127 (03) :777-791